Report Coverage
This report examines the manufacture and supply of medical and surgical equipment in South Africa. It analyses the industry value chain, the size and performance of the domestic industry, key trends, challenges and opportunities, trade dynamics, regulatory developments, enterprise development, regional and international markets, and the factors shaping industry competitiveness and growth. The report also profiles 61 notable companies operating in the sector, including Ascendis Health, B. Braun Medical, Fresenius Kabi, Johnson & Johnson Medical, Medtronic Africa, Roche Products, Siemens Healthcare, and Sinapi Biomedical.
Introduction
Introduction
• The South African medical devices industry encompasses the manufacture, importation, distribution and servicing of a wide range of medical and surgical equipment used across the public and private healthcare sectors.
• According to the US International Trade Administration (ITA), the total value of medical device sales in South Africa rose by 3.7% to R25.5bn in 2025, up from R24.6bn in 2024.
• The industry is characterised by a strong reliance on imported technologies and devices, complemented by a smaller but growing domestic manufacturing base.
• The medical technology industry is a key focus of South Africa's industrialisation agenda, with government and industry stakeholders working to strengthen local manufacturing capabilities, increase localisation, and reduce dependence on imported medical products.
• These objectives are supported by the Medical Technology Master Plan, launched by the Department of Trade, Industry and Competition in 2024.
• The plan aims to position South Africa as a regional medical technology hub, improve supply chain resilience, and support broader healthcare outcomes by expanding domestic production, attracting investment, enhancing competitiveness, deepening supplier development, and increasing participation in regional and global value chains.
Trends
• AI-enabled medical devices are becoming increasingly prevalent across diagnostics, imaging, patient monitoring and surgical applications.
• Globally, multi-site manufacturing strategies are increasingly common as companies seek to reduce reliance on single-country production hubs.
• Healthcare and medical device companies are diversifying their supply chains to strengthen resilience to geopolitical and trade-related disruptions.
• In South Africa, there is a growing focus on localisation initiatives, supported by government efforts to reduce import dependence and strengthen domestic production capabilities.
• Medical device business models are shifting from capital equipment sales to service-based revenue models centred on usage, outcomes and subscriptions. Pay-per-use pricing models are gaining traction, allowing healthcare providers to pay based on actual device utilisation rather than on upfront capital expenditure.
• Medical device manufacturers are creating new revenue streams by commercialising anonymised data insights and analytics services.
• Population ageing, coupled with the rising incidence of non-communicable diseases such as cardiovascular disease, diabetes and cancer, is driving increased demand for medical devices, advanced diagnostics, patient monitoring systems and healthcare services.
• Software, AI capabilities and cloud-based services are increasingly bundled with medical devices and monetised through subscription fees.
• South African medical technology regulatory standards are increasingly aligned with international standards.
• Suppliers are increasingly using proprietary accessories, consumables and reagents to create long-term customer lock-in and recurring revenue.
• The adoption of Internet of Medical Things (IoMT) technology is enabling predictive maintenance, improving equipment uptime and operational efficiency.
• The growing adoption of connected medical technologies is elevating cybersecurity as a key priority for regulation, compliance and risk management.
Opportunities
• Capturing opportunities arising from regulatory convergence with international standards by developing compliant products that can compete across multiple markets.
• Developing locally relevant AI solutions and diagnostic algorithms tailored to South Africa’s disease burdens, healthcare challenges and resource constraints.
• Developing remote monitoring and telehealth-enabled devices to support decentralised care delivery and improve patient access to healthcare services.
• Expanding AI-enabled products to improve diagnostic accuracy, clinical decision-making and workflow efficiency.
• Expanding production and distribution networks to strengthen supply chain resilience and reduce exposure to geopolitical and trade-related disruptions.
• Export growth into other African countries presents opportunities for manufacturers and distributors that can navigate regulatory requirements.
• Introducing pay-per-use commercial models to improve affordability for public and private healthcare providers.
• Investing in local manufacturing and assembly capabilities to benefit from localisation initiatives, public procurement preferences and potential incentives.
• Leveraging aggregated device data to develop new analytics services for healthcare providers, researchers, pharmaceutical companies and insurers.
• Providing equipment-as-a-service solutions that reduce upfront capital requirements for healthcare providers while improving supplier revenue predictability.
• Supporting healthcare providers with operational and clinical performance insights to improve outcomes, efficiency and resource utilisation.
• Targeting growing demand for connected healthcare ecosystems by integrating devices, software platforms, patient records and remote monitoring solutions.
Challenges
• An evolving regulatory environment creates uncertainty for manufacturers and distributors.
• Competition from multinational manufacturers pressures local companies' pricing, market share and profitability.
• Fiscal pressures on the public sector may reduce procurement volumes and delay investment in new healthcare infrastructure and technologies.
• Global geopolitical tensions and trade restrictions increase the risk of supply shortages, longer lead times and higher procurement costs.
• Growing cybersecurity risks associated with connected devices, AI applications and digital health platforms heighten compliance, operational and reputational risks.
• Healthcare cost-containment measures by both public and private funders may slow the adoption of new technologies and put pressure on pricing structures.
• Heavy reliance on imported medical devices and components exposes the industry to exchange-rate volatility and global supply-chain disruptions.
• High regulatory compliance and certification costs, particularly for Class C and D devices, raise operating costs and hinder innovation.
• Payment delays, particularly for public-sector orders, continue to strain suppliers' cash flow, working capital and business sustainability.
• Skills shortages in specialised technical, regulatory and digital disciplines may constrain innovation, manufacturing capability and sector growth.
• Underdeveloped and fragmented regulatory frameworks across many African markets create barriers to regional expansion and complicate market entry.
• Underfunding of research and development (R&D) limits innovation, product development and the industry's long-term global competitiveness.
• Weak economic growth and high unemployment are limiting healthcare affordability and constraining private healthcare spending and government healthcare budgets.
Outlook
• Despite a projected decline in 2026 sales, the South African medical devices industry is expected to remain resilient over the medium term. Growth prospects are supported by rising healthcare needs associated with an ageing population and a growing burden of chronic diseases, as well as policy initiatives aimed at expanding local manufacturing capacity and reducing import dependence.
• Demand is likely to be strongest in diagnostics, imaging, patient monitoring, minimally invasive procedures, digital health and AI-enabled solutions.
• The growing adoption of digital health, remote monitoring and Internet of Medical Things (IoMT)-enabled devices is creating opportunities for more efficient, service-based healthcare delivery models, while advances in artificial intelligence are enhancing diagnostic accuracy, clinical decision-making and operational efficiency across the healthcare system.
• Government support for localisation and domestic manufacturing may further stimulate local production, reduce reliance on imports and strengthen supply chain resilience.
• The industry's growth prospects may be moderated by low economic growth, fiscal constraints and high unemployment, which are limiting healthcare affordability and constraining public healthcare expenditure.
• Although the implementation of National Health Insurance (NHI) could expand access to healthcare services and increase utilisation of medical devices, centralised NHI procurement mechanisms could put pressure on supplier margins, particularly for smaller industry participants.
• Companies that successfully leverage AI, digital health technologies, recurring-revenue business models and localisation opportunities, while effectively managing regulatory, cybersecurity and economic risks, are likely to be best positioned for growth.
Full Report
R 20 000.00(ZAR) estimated $1250.56 (USD)*
Industry Landscape
R 14 000.00(ZAR) estimated $ 875.39 (USD)*
Historical Reports
The Manufacture and Supply of Medical, Surgical and Orthopaedic Equipment in South Africa 2020-11-30
R 1 900.00(ZAR) estimated $118.80 (USD)*
View Report Add to CartThe Manufacture and Supply of Medical, Surgical and Orthopaedic Equipment in South Africa 2019-05-15
R 1 900.00(ZAR) estimated $118.80 (USD)*
View Report Add to CartThe Manufacture and Supply of Medical, Surgical and Orthopaedic Equipment in South Africa 2017-05-24
R 1 900.00(ZAR) estimated $118.80 (USD)*
View Report Add to CartTable of Contents
[ Close ]| PAGE | ||
|---|---|---|
| 1. | INTRODUCTION | 1 |
| 2. | DESCRIPTION OF THE INDUSTRY | 1 |
| 2.1. | Industry Value Chain | 3 |
| 2.2. | Geographic Position | 5 |
| 2.3. | Size of the Industry | 6 |
| 3. | LOCAL | 14 |
| 3.1. | State of the Industry | 14 |
| 3.2. | Key Trends | 17 |
| 3.3. | Key Issues | 18 |
| 3.4. | Notable Players | 21 |
| 3.5. | Trade | 26 |
| 3.6. | Corporate Actions | 29 |
| 3.7. | Regulations | 29 |
| 3.8. | Enterprise Development and Social Development | 32 |
| 4. | AFRICA | 33 |
| 5. | INTERNATIONAL | 39 |
| 6. | INFLUENCING FACTORS | 44 |
| 6.1. | Unforeseen Events | 44 |
| 6.2. | Economic Environment | 45 |
| 6.3. | Labour | 47 |
| 6.4. | Environmental Issues | 49 |
| 6.5. | Technology, R&D, Innovation | 50 |
| 6.6. | Government Support | 52 |
| 6.7. | Input Costs | 53 |
| 7. | COMPETITIVE ENVIRONMENT | 54 |
| 7.1. | Competition | 54 |
| 7.2. | Ownership Structure of the Industry | 56 |
| 7.3. | Barriers to Entry | 57 |
| 8. | INDUSTRY SUMMARY | 60 |
| 9. | OUTLOOK | 62 |
| 10. | INDUSTRY ASSOCIATIONS | 63 |
| 11. | REFERENCES | 64 |
| 11.1. | Publications | 64 |
| 11.2. | Websites | 65 |
| ANNEXURE 1 – Industry Legislation | 66 | |
| ANNEXURE 2 – Harmonised System (HS) Codes | 71 | |
| APPENDIX 1 – Summary of Notable Players | 72 | |
| COMPANY PROFILES | 83 | |
| A P S TERAPIE SUID-AFRIKA CC | 83 | |
| ACINO HEALTHCARE GROUP (PTY) LTD | 84 | |
| ASCENDIS HEALTH LTD | 86 | |
| B BRAUN MEDICAL (PTY) LTD | 91 | |
| BAXTER HEALTHCARE SOUTH AFRICA (PTY) LTD | 94 | |
| BECTON DICKINSON (PTY) LTD | 96 | |
| BRITTAN HEALTHCARE (PTY) LTD | 98 | |
| BSN MEDICAL (PTY) LTD | 100 | |
| CAPRICORN BIOMEDICAL (PTY) LTD | 102 | |
| CE MOBILITY WHEELCHAIRS (PTY) LTD | 104 | |
| CHAMPION HEALTH CARE (PTY) LTD | 106 | |
| CONSULENS MEDICAL HEALTHCARE SOLUTIONS (PTY) LTD | 108 | |
| DEMANT SOUTH AFRICA (PTY) LTD | 110 | |
| DIS-CHEM PHARMACIES LTD | 112 | |
| DRAGER SOUTH AFRICA (PTY) LTD | 126 | |
| ELECTRO SPYRES MEDICAL (PTY) LTD | 128 | |
| ELITE SURGICAL SUPPLIES (PTY) LTD | 130 | |
| EVERGREEN LATEX CC | 132 | |
| FORTIS X (PTY) LTD | 134 | |
| FRESENIUS KABI MANUFACTURING SA (PTY) LTD | 135 | |
| FRESENIUS KABI SOUTH AFRICA (PTY) LTD | 137 | |
| FRESENIUS MEDICAL CARE SOUTH AFRICA (PTY) LTD | 140 | |
| GABLER MEDICAL (PTY) LTD | 142 | |
| GE HEALTHCARE (PTY) LTD | 144 | |
| GROBIR MEDICAL SUPPLIERS (PTY) LTD | 146 | |
| HUTZ HOSPI TEC (PTY) LTD | 148 | |
| IDT DIAGNOSTICS CC | 150 | |
| IMVULA HEALTHCARE LOGISTICS (PTY) LTD | 152 | |
| JOHNSON AND JOHNSON MEDICAL (PTY) LTD | 154 | |
| LODOX SYSTEMS (PTY) LTD | 156 | |
| M AND L MEDICAL SUPPLIERS CC | 158 | |
| MEDI-SAFE SURGICALS (PTY) LTD | 159 | |
| MEDICAL DIAGNOSTECH (PTY) LTD | 161 | |
| MEDICAL INNOVATIONS (PTY) LTD | 163 | |
| MEDINOX (PTY) LTD | 165 | |
| MEDLOYD HEALTHCARE (PTY) LTD | 167 | |
| MEDTRONIC (AFRICA) (PTY) LTD | 169 | |
| MEGROTEX (PTY) LTD | 171 | |
| MINOAN MEDICAL (PTY) LTD | 172 | |
| MOULDPROD EXHIBITIONS LTD | 174 | |
| MULTISURGE (PTY) LTD | 176 | |
| NEW CLICKS SOUTH AFRICA (PTY) LTD | 178 | |
| NTSHATSHELI TRADING (PTY) LTD | 182 | |
| ORTHOPAEDIC SUPPLIERS CC | 183 | |
| PHILIPS SOUTH AFRICA COMMERCIAL (PTY) LTD | 185 | |
| RADICAL MOBILITY (PTY) LTD | 187 | |
| ROCHE DIABETES CARE SOUTH AFRICA (PTY) LTD | 188 | |
| ROCHE PRODUCTS (PTY) LTD | 190 | |
| SA BIOMEDICAL HOLDINGS (PTY) LTD | 193 | |
| SAFMED (PTY) LTD | 195 | |
| SHONAQUIP (PTY) LTD | 197 | |
| SIEMENS HEALTHCARE (PTY) LTD | 199 | |
| SINAPI BIOMEDICAL (PTY) LTD | 201 | |
| SOUTHERN IMPLANTS (PTY) LTD | 203 | |
| SOUTHERN MEDICAL (PTY) LTD | 205 | |
| SSEM MTHEMBU MEDICAL (PTY) LTD | 207 | |
| STRYKER SOUTH AFRICA (PTY) LTD | 209 | |
| TELEFLEX MEDICAL (PTY) LTD | 211 | |
| TI-TAMED (PTY) LTD | 213 | |
| VERTICE HEALTHCARE (PTY) LTD | 215 | |
| YMS MEDICAL SUPPLIES (PTY) LTD | 217 |

